SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
89Omeros Announces Closing of $34.5 Million Public Offering of Common Stock SEATTHoward Williams-7/2/2012
88While those of us with OMER stock found this last week to be unpleasant (except Howard Williams-6/30/2012
87OMER insider buying this week ........ $150,000 http://www.sec.gov/Archives/eHoward Williams-6/30/2012
86To learn about OMER ..... ..... a good way to start would be to listen to theHoward Williams-6/20/2012
85Another good week ...... closed at $12.90. And OMER made the final list of RussHoward Williams-6/16/2012
84Duh ...... OMER IS in the prospective 2012 Russell 2000 Index. The Russell 2000Howard Williams-6/9/2012
832012 Russell index additions OMER is on the 2012 additions list for the RussellHoward Williams-6/9/2012
82Seeking Alpha today (6/6/12) ....... **************************** http://seekingHoward Williams-6/6/2012
81A couple more OMER mentions today ......... excerpts provided (OMER also had an Howard Williams-6/4/2012
80A relatively minor item ..... *********************************** Omeros AnnouncHoward Williams-5/31/2012
79Semi-Annual Changes to the NASDAQ Biotechnology Index http://www.globenewswireHoward Williams-5/14/2012
78 Omeros Corporation Reports First Quarter 2012 Financial Results PR Newswire Howard Williams-5/10/2012
77Omeros Adds Four More Unlocked Orphan GPCRs To Its Portfolio – Now Totaling 37,Howard Williams-5/3/2012
76SEATTLE, May 2, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biophHoward Williams-5/2/2012
75Omeros Announces Enrollment In Second Phase 3 Clinical Trial Evaluating OMS302 Howard Williams-4/10/2012
74Omeros Corporation Continues To Look Strong By Brian Wilson Thursday, 29 MarHoward Williams-3/29/2012
73Omeros Reports Allowance of Additional Patent for Ophthalmology Product OMS302 Howard Williams-3/29/2012
72Omeros Names Dr. Patrick Gray as Scientific Fellow March 27, 2012 07:01 AM EDT Howard Williams-3/27/2012
71Full Rodman & Renshaw report raising Omeros' target price to $16/share: Howard Williams-3/25/2012
70Omeros Price Target raised to $20/share by WBB Securities i3investor.comTheMaster-3/22/2012
69Omeros Eying deals as Opthalmology Drug succeeds seekingalpha.comTheMaster13/15/2012
68Couldn't agree more, bp1. With two more sets of Phase 3 results coming thisHoward Williams-3/13/2012
67Very impressive day for Omeros and I believe the best is yet to come.Bradpalm1-3/13/2012
66What analysts are saying ...... "Omeros Corporation (OMER) rated Mkt OutpeHoward Williams-3/13/2012
65 Omeros' Ophthalmology Product OMS302 Achieves Primary and Secondary EndpoinHoward Williams-3/13/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News